Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Kruppel-like factor 8 pseudogene (KLF8P1; ENSG00000275905) is a nonfunctional genomic DNA segment that resembles the protein-coding gene KLF8 but contains disabling mutations that prevent proper transcription or translation[1][4][5][7]. Pseudogenes do not encode functional proteins and typically lack regulatory elements required for gene expression. While some pseudogenes can exert RNA-based regulatory effects or act as genomic markers, there is no published evidence that KLF8P1 has any established biological, pathological, or therapeutic function[1][3][5][7]. Its presence may complicate molecular genetics assays, such as PCR, by sharing sequence similarity with the functional KLF8 gene[5]. It is not considered a drug target, receptor, enzyme, or any molecule with known clinical relevance. Key technical notes: - This is not a protein-coding gene, receptor, transporter, or enzyme but a *pseudogene*, a genomic relic. - There is no evidence for a functional protein, drug targeting, or biomarker role for KLF8P1[7]. - Pseudogenes sometimes possess noncoding regulatory functions, but such a role for KLF8P1 has not been documented[3]. - If you are looking for the functional Kruppel-like factor 8 gene (KLF8), this is a different locus and gene (see ENSG00000102349 for the active KLF8 gene)[2][8]. - Entry is likely considered "incorrect" or "not a target" for most molecular targeting purposes. If you require molecular target information for Kruppel-like factor 8 protein (KLF8), refer specifically to KLF8 (ENSG00000102349), not KLF8P1 (ENSG00000275905)[2][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kruppel-like factor 8 pseudogene (KLF8P1).